FOLFIRI and Cetuximab Every Second Week for First-Line Treatment of KRAS Wild-Type Metastatic Colorectal Cancer According to Phosphatase and Tensin Homolog Expression: A Phase II Study.

Autor: Personeni, Nicola, Rimassa, Lorenza, Verusio, Claudio, Barni, Sandro, Rubino, Luca, Bozzarelli, Silvia, Villa, Eugenio, Carnaghi, Carlo, Tronconi, Maria Chiara, Gerardi, Chiara, Galli, Francesca, Floriani, Irene, Destro, Annarita, Raschioni, Carlotta, Labianca, Roberto, Santoro, Armando
Zdroj: Clinical Colorectal Cancer; Sep2015, Vol. 14 Issue 3, p162-169, 8p
Databáze: Complementary Index
Externí odkaz: